Last reviewed · How we verify
Non preserved ocular lubricants
At a glance
| Generic name | Non preserved ocular lubricants |
|---|---|
| Sponsor | Abilion Medical Systems AB |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Artificial Tears, Tear Lipids and Tear Film Dynamics (PHASE4)
- Intra-Nasal Mechanical Stimulation (INMEST) As a Treatment Method for the Relief of Symptoms of Dry Eye (NA)
- Topical Insulin in Neurotrophic Keratopathy After Diabetic Vitrectomy
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Non preserved ocular lubricants CI brief — competitive landscape report
- Non preserved ocular lubricants updates RSS · CI watch RSS
- Abilion Medical Systems AB portfolio CI